Strengths
Evercode™ offers a user-friendly platform that simplifies the single-cell sequencing process, making it accessible to a wider range of researchers.
The technology provides high-quality data output, including the ability to detect lowly expressed genes, which is crucial for in-depth biological insights.
Evercode™ eliminates the need for specialized instruments, allowing researchers to conduct experiments with common laboratory equipment, thus reducing setup costs.
The platform supports scalable experiments, enabling researchers to analyze from 1,000 to 1 million cells in a single run, which enhances experimental flexibility.
Parse Biosciences has established a strong brand positioning as an innovative startup dedicated to advancing single-cell research, which resonates well with its target audience.
The end-to-end solution from sample preparation to data analysis streamlines the workflow for researchers, saving time and resources.
The partnership with Gencell Pharma to expand into South America opens new markets and enhances brand visibility in the biotechnology sector.
Evercode™ utilizes combinatorial barcoding technology, which significantly improves data quality by avoiding ambient RNA contamination, a common issue in traditional methods.